Trial of a new bypass graft for heart surgery
Part of Heart & circulation clinical trials.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need bypass surgery on at least two heart arteries, including one to the main front artery (LAD).
- You must be between 45 and 75 years old.
- Your heart's pumping strength (ejection fraction) must be 35% or higher.
- You cannot have had open-heart surgery before.
- You must not have poorly controlled diabetes (A1C above 8) or serious kidney disease (GFR below 45).
- You must be willing to take blood-thinning medicines as prescribed after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This study compares two surgical techniques for heart bypass: using the left internal thoracic artery in one specific way versus another. It may help improve how well the bypass works in people who need bypass surgery for multiple blocked heart arteries.
This trial is comparing two common heart procedures—bypass surgery (CABG) and stents (PCI)—to see which works better for women with blockages in multiple heart arteries. It aims to find the best treatment for women, who are often underrepresented in heart research.
This trial compares using only your own arteries (like the radial artery in your arm) versus using a mix of arteries and leg veins for bypass grafts. It aims to see which approach works better for people with multiple blocked heart arteries.
This trial tests whether a blood-thinner drug called cangrelor helps patients who are having a special type of bypass surgery that uses a small incision instead of opening the whole chest. The surgery connects a healthy artery from your chest wall directly to a blocked heart vessel to restore blood flow.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.